search
Back to results

Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching

Primary Purpose

Inflammation, Pulpitis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ibuprofen.
Sponsored by
Universidade Estadual de Ponta Grossa
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inflammation focused on measuring Analgesics, Ibuprofen, Inflammation, Tooth Bleaching

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients included in this clinical trial were:
  • at least 18 years old.
  • had good general and oral health.
  • the participants should have eight caries-free maxillary and jaw anterior teeth and without restorations on the labial surfaces.
  • the central incisors should be shade C2 or darker.

Exclusion Criteria:

  • participants that had undergone tooth-whitening procedures.
  • presenting anterior restorations.
  • pregnant/lactating.
  • with severe internal tooth discoloration (tetracycline stains, fluorosis, pulpless teeth).
  • taking any kind of medicine, bruxism habits or any other pathology that could cause sensitivity (such as recession, dentine exposure).
  • participants that reported some earlier or present health problems in stomach, heart, kidney and liver, or participants using any continuous drug with anti-inflammatory and antioxidant action were excluded from the study.

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Tooth sensitivity evaluation
    Patients will be distributed in two groups: Group 1 - Control Group will receive placebo. Group 2 - Ibuprofen will receive not selective anti-inflammatory (Ibuprofen 400 mg). All of the drugs will be administered one hour before the bleaching treatment. Evaluation of Dental Sensitivity Level: the effect of the product will be evaluated up to 1 Hour, 24 and 48 hours after the tooth bleaching, using a verbal scale of 5 points and a Visual Analogue Scale (VAS) will be used.

    Secondary Outcome Measures

    Shade evaluation
    Shade evaluation was recorded using two methods: the subjective evaluation using a shade guide (Vita Lumin, Vita Zahnfabrik, Bad Säckingen, Germany) and an objective evaluation using the spectrophotometer (Easyshade, Vident, Brea, CA, USA).

    Full Information

    First Posted
    December 13, 2011
    Last Updated
    February 8, 2012
    Sponsor
    Universidade Estadual de Ponta Grossa
    Collaborators
    Fundação Araucária
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01530217
    Brief Title
    Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching
    Official Title
    Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching: a Randomized, Triple-blind Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2012
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2011 (undefined)
    Primary Completion Date
    April 2011 (Actual)
    Study Completion Date
    May 2011 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Universidade Estadual de Ponta Grossa
    Collaborators
    Fundação Araucária

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Ibuprofen has been recognized as anti-inflammatory and analgesic. The purpose of this study is to determine the effect of ibuprofen 400 mg on tooth sensitivity (TS) caused by in-office bleaching. Methods: 30 health adults who received either placebo or ibuprofen. The drugs were administered 1 hour prior to the bleaching and will be prescribed 5 doses every 8 hours during 48 hours. For bleaching will be used 35% hydrogen peroxide gel. The tooth sensitivity will be recorded for up and lower arc on two scales: VAS (visual analogic scale) and 0-4. The shade evaluation will be performed before and 30 days after bleaching with visual shade guide and spectrophotometer.
    Detailed Description
    Background: Ibuprofen has been recognized as anti-inflammatory and analgesic. The purpose of this study was to determine the effect of ibuprofen 400 mg on tooth sensitivity (TS) caused by in-office bleaching. Methods: A triple-blind, parallel design, randomized clinical trial will be conducted on 30 health adults who received either placebo or ibuprofen. The drugs will be administered 1 hour prior to the bleaching and a every eight hours during 48 hours. For bleaching used 35% hydrogen peroxide gel. The TS will be recorded for up and lower arc on two scales: VAS and 0-4. The shade evaluation will be performed before and 30 days after bleaching with visual shade guide and spectrophotometer. The % of patients that reported TS at least once during treatment and the TS intensity will be evaluated by Fisher's and Mann-Whitney tests, respectively. The color changes will be evaluated by repeated measures ANOVA.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Inflammation, Pulpitis
    Keywords
    Analgesics, Ibuprofen, Inflammation, Tooth Bleaching

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    ParticipantInvestigatorOutcomes Assessor
    Allocation
    N/A
    Enrollment
    30 (Actual)

    8. Arms, Groups, and Interventions

    Intervention Type
    Drug
    Intervention Name(s)
    Ibuprofen.
    Other Intervention Name(s)
    Uniprofen / National Pharmaceutical Chemistry União S / A.
    Intervention Description
    Ibuprofen Group will be receive a dose of non-steroidal antiinflammatory drug ibuprofen 400 mg. All the participants will be watched to ensure that they took the drugs 1 hour prior to treatment. A second dose of ibuprofen (400 mg), will be administered a every 8 hours after the first dose during 48 hours.
    Primary Outcome Measure Information:
    Title
    Tooth sensitivity evaluation
    Description
    Patients will be distributed in two groups: Group 1 - Control Group will receive placebo. Group 2 - Ibuprofen will receive not selective anti-inflammatory (Ibuprofen 400 mg). All of the drugs will be administered one hour before the bleaching treatment. Evaluation of Dental Sensitivity Level: the effect of the product will be evaluated up to 1 Hour, 24 and 48 hours after the tooth bleaching, using a verbal scale of 5 points and a Visual Analogue Scale (VAS) will be used.
    Time Frame
    Sensitivity during the treatment and until 48 hours after bleaching. The tooth sensitivity will be evaluated only this period because the literature appoint dates in this time.
    Secondary Outcome Measure Information:
    Title
    Shade evaluation
    Description
    Shade evaluation was recorded using two methods: the subjective evaluation using a shade guide (Vita Lumin, Vita Zahnfabrik, Bad Säckingen, Germany) and an objective evaluation using the spectrophotometer (Easyshade, Vident, Brea, CA, USA).
    Time Frame
    Shade evaluation was recorded before and 30 days after the bleaching treatment.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patients included in this clinical trial were: at least 18 years old. had good general and oral health. the participants should have eight caries-free maxillary and jaw anterior teeth and without restorations on the labial surfaces. the central incisors should be shade C2 or darker. Exclusion Criteria: participants that had undergone tooth-whitening procedures. presenting anterior restorations. pregnant/lactating. with severe internal tooth discoloration (tetracycline stains, fluorosis, pulpless teeth). taking any kind of medicine, bruxism habits or any other pathology that could cause sensitivity (such as recession, dentine exposure). participants that reported some earlier or present health problems in stomach, heart, kidney and liver, or participants using any continuous drug with anti-inflammatory and antioxidant action were excluded from the study.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Alessandra Reis, doctor
    Organizational Affiliation
    Universidade Estadual de Ponta Grossa
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Assessing of Tooth Sensitivity Using Ibuprofen Before in Office-tooth Bleaching

    We'll reach out to this number within 24 hrs